Q3 2024 · 13F-HR
Atle Fund Management ABholdings as filed
Filed 2024-11-12 · accession 0001381843-24-000008
$212.8M
Reported value
36
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 532457108 | LLY | ELI LILLY & CO | $27.1M | 12.7% | 30,564 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $20.8M | 9.75% | 35,490 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $17.6M | 8.26% | 154,699 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $13.6M | 6.40% | 22,012 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $9.3M | 4.39% | 28,965 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $8.9M | 4.18% | 106,172 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $8.8M | 4.13% | 44,486 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $8.5M | 3.98% | 23,460 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $8.2M | 3.87% | 36,544 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $7.9M | 3.71% | 16,993 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $7.4M | 3.47% | 7,028 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $7.0M | 3.28% | 60,607 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $6.6M | 3.11% | 236,610 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $6.2M | 2.91% | 84,578 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $6.1M | 2.86% | 151,875 | Common | SOLE |
| 902673102 | UFPT | UFP TECHNOLOGIES INC | $5.7M | 2.69% | 18,048 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $5.4M | 2.54% | 138,321 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $3.6M | 1.69% | 53,757 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $3.4M | 1.58% | 40,230 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $3.3M | 1.56% | 82,691 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $3.0M | 1.43% | 27,500 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $2.9M | 1.38% | 275,472 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $2.5M | 1.19% | 50,687 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $2.4M | 1.13% | 36,505 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $2.3M | 1.08% | 138,983 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $1.9M | 0.89% | 86,013 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $1.7M | 0.79% | 54,060 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $1.7M | 0.79% | 9,202 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $1.6M | 0.75% | 442,423 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $1.4M | 0.67% | 69,573 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $1.4M | 0.64% | 53,432 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $1.3M | 0.63% | 26,390 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $1.0M | 0.48% | 538,621 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $822,000 | 0.39% | 200,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $795,424 | 0.37% | 168,522 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $635,755 | 0.30% | 34,328 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.